Recon: AP report claims FDA faces backlog of 2,000 overdue inspections; Lykos CEO steps down after MDMA drug setback
ReconJason Scott
Audit/inspectionBiologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States